Ropeginterferon alfa-2b

From WikiMD.org
Jump to navigation Jump to search
Ropeginterferon alfa-2b
TermRopeginterferon alfa-2b
Short definitionRopeginterferon alfa-2b - (pronounced) (raw-peg-IN-ter-FEER-on AL-fuh.
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Ropeginterferon alfa-2b - (pronounced) (raw-peg-IN-ter-FEER-on AL-fuh. . . ) A medicine used to treat adults with polycythemia vera (a disease in which too many red blood cells are made in the bone marrow). It is also being studied in the treatment of other conditions and some types of cancer. Ropeginterferon alfa-2b is a form of recombinant interferon alfa-2b that's made in a laboratory and linked to a substance called PEG, which allows the drug to stay in the body longer. Ropeginterferon alfa-2b can reduce the number of red blood cells made in the bone marrow. It's a type of cytokine and a type of immunomodulating agent. Also called Besremi

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski